MedTrace Logo

Biologic Predictors of Leiomyoma Treatment Outcomes

NCT01936493 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2017-03-27

No results posted yet for this study

Summary

The purpose of this study is to search for the hereditary (genetic) causes of uterine fibroids. Some women with uterine fibroids may have one or more genes that make them more likely to develop uterine fibroids. We are trying to identify these genes to better understand how and why uterine fibroids develop and to design better treatment options for women with uterine fibroids. This information may also help us to understand and treat other problems that may be caused by these genes.

Conditions

  • Uterine Leiomyomas
  • Fibroids
  • Uterine Fibroids
  • Myomas

Interventions

GENETIC

DNA analysis

At a future time DNA analysis will be performed

OTHER

Hormonal analysis

Participants will provide blood samples so that hormonal factors that influence outcomes of leiomyoma treatments can be assayed.

Sponsors & Collaborators

  • Elizabeth A. Stewart

    lead OTHER

Principal Investigators

  • Elizabeth A. Stewart, M.D. · Mayo Clinic - Rochester, Minnesota

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2015-05-31
Completion
2015-05-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01936493 on ClinicalTrials.gov